Articles On Telix Pharmaceuticals (ASX:TLX)

Highlights: FDA approval for a new imaging agent by Telix Pharmaceuticals influences discussions across market sectors. Resource industry undergoes shifts with notable divestments and operational challenges due to climatic condit...

The ASX has been trading flat at around 7,922 points on Friday. Staples has been the best-performing sector, up 3%, followed by Industrials and Utilities, both up 0.5%. Health Care has been the worst-performing, down 0.6%, followed by...

Highlights:  US Markets Retreat: S&P 500 erased early gains, closing slightly lower amid a lack of clear market direction.  Central Banks in Focus: The Bank of England, Sweden, and Taiwan maintained interest rates, while Switzerlan...

S&P/ASX 200 Index (ASX: XJO) healthcare stock Telix Pharmaceuticals Ltd (ASX: TLX) is marching higher today. Shares in the diagnostic and therapeutic product developer closed yesterday trading for $27.80. In morning trade on Friday, sh...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have slipped by around 11% from their former highs of $31 apiece since February. This isn't a Telix-only issue. The S&P/ASX 200 Index (ASX: XJO) is also down 5% this past month. This comes...

It was a return to red ink for the S&P/ASX 200 Index (ASX: XJO) this Wednesday, as investors lost the steam that had been powering a recovery over the past few trading days. By the time trading w...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are pointing to another down day as traders take risk off the table ahea...

Despite the current political upheaval, the US health sector remains the first port of call for most biotechs FDA approvals have sparked one-day share surges of as much as 500% Several ASX companies await do-or-die FDA approvals Despite r...

Telix Pharmaceuticals’ Brazilian win marks its first foray into the South American market Orthocell gains approval to sell its dental guided bone regeneration product in Singapore Sigma Healthcare: great prospects, a pity about the valuati...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ — Teli...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A fall in airfares assisted a lower-than-expected February US Core CPI print (pre-ta...

S&P/ASX 200 Index (ASX: XJO) share Telix Pharmaceuticals Ltd (ASX: TLX) is slipping today. Shares in the diagnostic and therapeutic product developer closed yesterday trading for $26.61. In morning trade on Wednesday, shares are swappi...

Healthcare analysts say Neuren shares should be worth more than double what they are Biotech sector retreats in February, despite some record results Dimerix pockets $3.2 million payment from Japanese partner   Some healthcare analysts be...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., March 4, 2025 /PRNewswire/ — Telix P...

ASX 200 healthcare share Telix Pharmaceuticals Ltd (ASX: TLX) fell 9.4% to an intraday low of $27.52 as the market digested news of a $118 million off-market trade by the co-founders. The radiopharmaceutical company's CEO, Dr. Christian...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 0.75% to 8,205.8 points. Four ASX shares that are falling more than most today are l...

Highlights: Karoon Energy strengthens its operational framework with an asset acquisition for its Brazil-based project. Qantas announces a dividend reinstatement, reflecting financial recovery in the aviation sector. Fluctuations...

Good afternoon and welcome to the Thursday edition of Market Close, I’m Jonathon Davidson. It was a somewhat happier day as Australian icon Qantas paid its first dividend in years and household name Coles proved to be consistently growing....

Highlights  Strong Start: ASX opens higher, driven by consumer staples and aviation sectors.  Corporate Moves: Notable stock movements include (ASX:COL), (ASX:QAN), (ASX:RHC), and (ASX:IDP).  Tech Sector Volatility: Nvidia’s earnings...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are signalling yet anolther uninspiring, downbeat session lays ahead for...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Feb. 26, 2025 /PRNewswire/ – Telix Pharmaceuticals Limited...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures are suggesting another cautious, slightly weaker opening for the ASX tod...

Like London buses, takeovers tend to come in a rush Mayne Pharma had struggled for years, but its performance was improving Takeovers in the ASX biotech sector have been few and far between The ‘London’ Bus theory goes that if one takeove...

Right now, I own Pro Medicus Ltd (ASX: PME) shares, Resmed CDI(ASX: RMD) shares and Telix Pharmaceuticals Ltd (ASX: TLX) shares, and previously owner Xero Ltd (ASX: XRO) shares. This article explains why I own PME, RMD and TLX, and some of...

S&P/ASX 300 Index (ASX: XKO) shares are currently down 0.66% to 8,185.70 points. Meantime, several companies in the index have hit new share price highs today. ASX 300 shares setting new price records on Tuesday Telix Pharmaceu...

The ASX is cruising along in 2025, extending a solid run for the S&P/ASX 200 Index (ASX: XJO). In the past year, it has climbed 655 points, or more than 8.5%. According to the experts, investors searching for shares with even greate...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Australian shares are set to open lower following a choppy session on Wall Street, a...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AX1)) - Accen...

It's been a wild start to the trading week this Monday for ASX investors. After taking a deep plunge at market open this morning, the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 stocks have since recovered. The index has currently bro...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

Telix expects three more US product approvals this year Patrys switches to plan B Biotron’s do-or-die $500,000 capital raising   Analysts reckon Telix Pharmaceuticals (ASX:TLX) has only just started to reach its full potential, with three...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have been on an absolute tear over the past year, surging an incredible 175%. And according to the team at Bell Potter, this high-flying ASX 200 share may have even more room to run. This morning,...

It was a disappointing end to a horrid trading week for the S&P/ASX 200 Index (ASX: XJO). After falling every day this week, the ASX 200 capped off Friday's session with a 0.32% sell-down. Tha...

ASX hovers near one-month low, dragged by GYG and banks Domain soars on takeover bid RBA’s bullock admits slow rate hikes, while Alibaba rebounds   The ASX had a rough afternoon on Friday, with the market closing near its one-month low. D...

Highlights  ASX 200 edges lower as consumer discretionary stocks struggle.  Commonwealth Bank (ASX:CBA) and major banks face downward pressure.  Domain (ASX:DHG) surges on takeover speculation, while REA Group (ASX:REA) drops.  Th...

The S&P/ASX 200 Index (ASX: XJO) is rebounding slightly from yesterday's selloff. At the time of writing, the benchmark index is up 0.15% to 8,335.9 points. Four ASX shares that are rising more than most today are listed below. Here's...

Highlights  S&P 500 declines: The index retreats from record highs following weak Walmart guidance and renewed tariff concerns.  ASX 200 futures rise: Local markets set for a rebound after three consecutive sessions of declines. ...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher on Friday morning. At the time of writing, the pharmaceutical company's shares are up 13% to a record high of $30.00. This follows the release of its full year results af...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a very disappointing session and dropped deep into the red. The benchmark index fell 1.15% to 8,322.8 points. Will the market be able to bounce back from this on Friday and end the wee...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ – Telix P...

S&P/ASX 200 Index (ASX: XJO) healthcare stock Telix Pharmaceuticals Ltd (ASX: TLX) has delivered some smashing returns to shareholders, both over the short and long term. And it looks well-placed to continue outperforming. Shares in th...

Highlights Several ASX-listed biotech companies are nearing FDA approval, signifying potential entry into the crucial U.S. market. The FDA has improved its communication with applicants, fostering a more predictable approval process....

Highlights  ASX 200 Futures remained steady, up 2 points (+0.02%) as of 8:30 am AEDT, signaling a cautious market open.  Commonwealth Bank of Australia (ASX:CBA) reported first-half FY25 net profit after tax (NPAT) growth of 2%, slight...

Having lodged their paperwork, companies including EBR Systems, Artyra and Orthocell await crucial FDA approval The agency has improved its communications with applicants, which avoids nasty surprises Applicants are doing the commercial gr...

ASX 200 healthcare shares are up 0.47% amid a strong day for the Australian share market. The benchmark S&P/ASX 200 Index (ASX: XJO) is up 1.05% at the time of writing, as the first week of earnings season continues on Thursday....

The S&P/ASX 200 Index (ASX: XJO) snatched defeat from the jaws of victory today, letting an early surge slip away to finish slightly lower. Despite rising as much as 0.8% this morning, the ASX...

After the tariff-induced carnage that kicked off the trading week yesterday, the S&P/ASX 200 Index (ASX: XJO) and many ASX 200 stocks are bouncing back this Tuesday. At the time of writing, the index has added a healthy 0.43% and is bac...

It's been a great session for S&P/ASX 200 Index (ASX: XJO) stocks so far this Wednesday. At the time of writing, the ASX 200 has climbed by 0.85%, leaving the index at around 8,470 points. Although this hasn't quite lifted the ASX 20...

It was a wild and woolly start to the short trading week for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares this Tuesday. After an initial plunge this morning, the ASX 200 managed to rec...

S&P/ASX 200 Index (ASX: XJO) stocks are trading just inside the green at 8,419.7 points in late afternoon trade on Tuesday. The ASX 200 dipped then flipped in early trading after a sell-off on Wall Street overnight. The benchmark...